EDGAR Filing Documents for 0001493152-15-000645

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-15-000645

Filing Date

2015-02-24

Accepted

2015-02-24 08:34:54

Documents

Period of Report

2014-06-30

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm	10-Q	594795
2		ex31-1.htm	EX-31.1	15329
3		ex31-2.htm	EX-31.2	15490
4		ex32-1.htm	EX-32.1	5248
5		ex32-2.htm	EX-32.2	5327
	Complete submission text file	0001493152-15-000645.txt		6335322

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE FILE	corx-20140630.xml	EX-101.INS	688767
7	XBRL SCHEMA FILE	corx-20140630.xsd	EX-101.SCH	74829
8	XBRL CALCULATION FILE	corx-20140630_cal.xml	EX-101.CAL	42136
9	XBRL DEFINITION FILE	corx-20140630_def.xml	EX-101.DEF	267869
10	XBRL LABEL FILE	corx-20140630_lab.xml	EX-101.LAB	505026
11	XBRL PRESENTATION FILE	corx-20140630_pre.xml	EX-101.PRE	326061

Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452

Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)